SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-238229
Filing Date
2019-09-05
Accepted
2019-09-05 07:35:40
Documents
14
Period of Report
2019-09-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d791862d8k.htm   iXBRL 8-K 30645
2 EX-99.1 d791862dex991.htm EX-99.1 14530
6 GRAPHIC g791862g0905043652802.jpg GRAPHIC 6239
  Complete submission text file 0001193125-19-238229.txt   184084

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wve-20190904.xsd EX-101.SCH 3089
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20190904_lab.xml EX-101.LAB 18069
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20190904_pre.xml EX-101.PRE 11397
8 EXTRACTED XBRL INSTANCE DOCUMENT d791862d8k_htm.xml XML 3333
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 191076173
SIC: 2834 Pharmaceutical Preparations